Breaking News

Specialist CRO Expands Pharmacovigilance Capabilities

Quanticate makes investment ahead of the upcoming Article 2(3) of Directive 2010/84/EU

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quanticate has completed an investment initiative to upgrade its pharmacovigilance safety database and its in-house technology platform in preparation for the upcoming Article 2(3) of Directive 2010/84/EU that will impact the pharmaceutical industry later this year. The data-focused clinical research organization (CRO) has made the move following the European Medicines Agency’s (EMA) planned launch of an improved version of EudraVigilance, the European information system for suspected adverse...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters